GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 227 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $2,650,000 | 0.0% | 50,373 | 0.0% | 0.14% | +15.2% |
| Q2 2019 | $2,650,000 | +10092.3% | 50,373 | +7625.9% | 0.12% | +12400.0% |
| Q1 2019 | $26,000 | 0.0% | 652 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $26,000 | +18.2% | 652 | +11.5% | 0.00% | 0.0% |
| Q3 2018 | $22,000 | -38.9% | 585 | -27.2% | 0.00% | -75.0% |
| Q2 2018 | $36,000 | -7.7% | 804 | -0.6% | 0.00% | – |
| Q1 2018 | $39,000 | – | 809 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $68 | 0.00% |